SSB
TNYA icon

Sandy Spring Bank’s Tenaya Therapeutics TNYA Stock Holding History

Sandy Spring Bank’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,000
Closed -$2.86K – 1302
2024
Q4 		$2.86K Hold
2,000
– – ﹤0.01% 1026
2024
Q3 		$3.86K Hold
2,000
– – ﹤0.01% 981
2024
Q2 		$6.2K Hold
2,000
– – ﹤0.01% 956
2024
Q1 		$10.5K Buy
+2,000
New +$9.57K ﹤0.01% 842

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sandy Spring Bank's TNYA Position: Q1 2025 in Review

Sandy Spring Bank sold out of Tenaya Therapeutics (TNYA) in Q1 2025, closing a stake of 2,000 shares — an estimated $2.86K sold.

Sandy Spring Bank first reported a position in TNYA in Q1 2024 and held it in 4 quarters. The position peaked at $10.5K in Q1 2024. 107 funds tracked by Wall St. Rank hold TNYA as of Q1 2025.

  • Sandy Spring Bank reported no remaining Tenaya Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Sandy Spring Bank sold 2,000 Tenaya Therapeutics shares in Q1 2025, an estimated $2.86K.
  • Sandy Spring Bank first reported a position in Tenaya Therapeutics in Q1 2024 and held it in 4 quarters.
  • Sandy Spring Bank's Tenaya Therapeutics position peaked at $10.5K in Q1 2024.
  • 107 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.